ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Human Embryo Panel Defines Acceptable Research For Funding

September 30, 1994

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

NCCS Networker Volume 2 Issue 3, Summer 1988

June 13, 1988

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998